# Auburn National Bancorporation, Inc: overview AUBN · Nasdaq · CIK 750574 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/aubn.md) · [Financials](/companies/aubn/financials.md) · [Filings](/companies/aubn/filings.md) · [Insiders](/companies/aubn/insiders.md) Latest reported revenue: [$153.0k](/filings/0001193125-26-345021.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 11, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, accession 0001193125-26-345021). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [154](/filings/0001193125-25-277883.md) | [151 d](/filings/0001193125-26-111012.md) | [155](/filings/0001193125-26-221544.md) | [152](/filings/0001193125-26-345021.md) | [154](/filings/0001193125-25-277883.md) | [158 d](/filings/0001193125-26-111012.md) | [153](/filings/0001193125-26-221544.md) | [153](/filings/0001193125-26-345021.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | [1124.7%](/filings/0001193125-25-277883.md) | [1033.1% d](/filings/0001193125-26-111012.md) | [987.1%](/filings/0001193125-26-221544.md) | [1205.9%](/filings/0001193125-26-345021.md) | [1446.1%](/filings/0001193125-25-277883.md) | [1053.8% d](/filings/0001193125-26-111012.md) | [1436.6%](/filings/0001193125-26-221544.md) | [1502.0%](/filings/0001193125-26-345021.md) | | Diluted EPS | $ per share | [0.50](/filings/0001193125-25-277883.md) | not reported | [0.44](/filings/0001193125-26-221544.md) | [0.52](/filings/0001193125-26-345021.md) | [0.64](/filings/0001193125-25-277883.md) | not reported | [0.63](/filings/0001193125-26-221544.md) | [0.66](/filings/0001193125-26-345021.md) | | Free cash flow | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [0.6](/filings/0001193125-23-074092.md) | [0.6](/filings/0001193125-24-067944.md) | [0.6](/filings/0001193125-25-051574.md) | [0.6](/filings/0001193125-26-111012.md) | [0.6](/filings/0001193125-26-111012.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | [1420.3%](/filings/0001193125-23-074092.md) | [1730.1%](/filings/0001193125-24-067944.md) | [231.3%](/filings/0001193125-25-051574.md) | [1041.9%](/filings/0001193125-26-111012.md) | [1172.1%](/filings/0001193125-26-111012.md) | | Diluted EPS | $ per share | [2.27](/filings/0001193125-22-068826.md) | not reported | not reported | [1.83](/filings/0001193125-26-111012.md) | [2.08](/filings/0001193125-26-111012.md) | | Free cash flow | $m | [(7.9)](/filings/0001193125-23-074092.md) | [3.9](/filings/0001193125-24-067944.md) | [11.5](/filings/0001193125-25-051574.md) | [8.7](/filings/0001193125-26-111012.md) | [10.9](/filings/0001193125-26-111012.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareBasicAndDiluted; Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/aubn/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [LPL Financial LLC](/funds/1403438.md) | 2026-06-30 | $1.4m | 50,573 | | Unchanged | | [Truffle Hound Capital, LLC](/funds/1595862.md) | 2026-06-30 | $1.4m | 50,000 | | Unchanged | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $1.1m | 41,973 | | Added +126 | | [BRIDGEWAY CAPITAL MANAGEMENT, LLC](/funds/1107261.md) | 2026-06-30 | $898.0k | 33,211 | | Added +930 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $696.0k | 25,733 | | Added +504 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $688.1k | 25,447 | | Reduced −14,115 | | [Aptus Capital Advisors, LLC](/funds/1664193.md) | 2026-06-30 | $549.7k | 20,330 | | Reduced −6,960 | | [TRUIST FINANCIAL CORP](/funds/92230.md) | 2026-06-30 | $528.7k | 19,553 | | Unchanged | | [CAPTRUST FINANCIAL ADVISORS](/funds/1512024.md) | 2026-06-30 | $512.3k | 18,945 | | Reduced −243 | | [Fourthstone LLC](/funds/1767803.md) | 2026-06-30 | $481.5k | 17,806 | | New +17,806 | ## Recent filings [All 949 filings](/companies/aubn/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-27 | 10:37 ET | [8-K](/filings/0001437749-26-033582.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-033582 | | 2026-08-11 | 17:18 ET | [10-Q](/filings/0001193125-26-345021.md) | Quarterly report, period 2026-06-30 | 0001193125-26-345021 | | 2026-08-11 | 13:32 ET | [8-K](/filings/0001193125-26-344014.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-344014 | | 2026-07-28 | 15:32 ET | [8-K](/filings/0001193125-26-320838.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-320838 | | 2026-06-05 | 16:45 ET | [8-K](/filings/0001193125-26-259810.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-259810 | | 2026-05-13 | 17:07 ET | [8-K](/filings/0001193125-26-221919.md) | 5.07 Shareholder vote results | 0001193125-26-221919 | | 2026-05-13 | 15:59 ET | [10-Q](/filings/0001193125-26-221544.md) | Quarterly report, period 2026-03-31 | 0001193125-26-221544 | | 2026-05-13 | 10:33 ET | [8-K](/filings/0001193125-26-220850.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-220850 | | 2026-04-28 | 09:57 ET | [8-K](/filings/0001193125-26-184446.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-184446 | | 2026-04-02 | 12:49 ET | [DEF 14A](/filings/0001193125-26-139480.md) | Proxy statement, period 2026-05-12 | 0001193125-26-139480 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-111012.md), filed Mar 17, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, locked when the 8-K was accepted. It is scored when the 10-Q or 10-K is ingested. [See the target](/leagues/2026q3/targets/7eb9dc4c-f4e1-44cb-b743-7fa90933f8d9) ## About the filer - CIK: 750574 - Tickers: AUBN - Exchange: Nasdaq - SIC code: 6022 State Commercial Banks - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 10:38 ET. No prices; not investment advice.